MRTP application made for low nicotine cigarette

Goodrich Tobacco Company (GTC) has submitted a Modified Risk Tobacco Product (MRTP) application to the US Food and Drug Administration (FDA).

GTC is a wholly-owned subsidiary of the plant biotechnology company, 22nd Century Group.

GTC is said to be seeking a reduced exposure order so that 22nd Century’s ‘BRAND A’ very low nicotine cigarettes may be introduced commercially in the US.

The application to the FDA requests that BRAND A packaging and marketing be allowed to disclose to consumers that the company’s proprietary very low nicotine cigarettes reduce smokers’ exposure to nicotine.